Author:
Moehler Markus,Gepfner-Tuma Irina,Maderer Annett,Thuss-Patience Peter C.,Ruessel Joern,Hegewisch-Becker Susanna,Wilke Hansjochen,Al-Batran Salah-Eddin,Rafiyan Mohammad-Reza,Weißinger Florian,Schmoll Hans-Joachim,Kullmann Frank,von Weikersthal Ludwig Fischer,Siveke Jens T.,Weusmann Jens,Kanzler Stephan,Schimanski Carl Christoph,Otte Melanie,Schollenberger Lukas,Koenig Jochem,Galle Peter R.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference47 articles.
1. Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, Middleton G, Daniel F, Oates J, Norman AR. Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med. 2008;358(1):36–46.
2. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, Fleig WE. Chemotherapy for advanced gastric cancer. The Cochrane database of systematic reviews. 2010;3, CD004064.
3. Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, Kurteva G, Volovat C, Moiseyenko VM, Gorbunova V, et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14(6):490–9.
4. Pasini F, Fraccon AP, Dem G. The role of chemotherapy in metastatic gastric cancer. Anticancer Res. 2011;31(10):3543–54.
5. Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist. 2005;10 Suppl 3:49–58.
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献